Publications by authors named "N Kaci"

Claim this Profile
J
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.
Nabih Maslah, Nina Kaci, Blandine Roux, Gabriela Alexe, Raphael Marie

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia.
Jacqueline H Starrett, Clara Lemoine, Matthias Guillo, Chantal Fayad, Nabil Kaci

JCI Insight· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of thyroid antigens in the female reproductive system.
Selma Aissiou, Nadjia Boucekkine, Eoghan M Cunnane, Nasrin G Gashti, Amina Oumeziane, Naima Kaci

Afr J Reprod Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose infigratinib increases bone growth and corrects growth plate abnormalities in an achondroplasia mouse model.
Benoit Demuynck, Justine Flipo, Nabil Kaci, Carl Dambkowski, Morgan Paull

J Bone Miner Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice.
Léa Loisay, Davide Komla-Ebri, Anne Morice, Yann Heuzé, Camille Viaut, Nabil Kaci

JCI Insight· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis